7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one

Product Name: 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one
CAS No.: 4425-23-4
Chemical Name: 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one
Synonyms: RLX;PD-139530;2,3-Pentanoquinazoline-4(3H)-one;VASICINONE HCl (Deoxydihomo-'c'-);7,8,9,10-Tetrahydro-6H-azepino[2,1-b]quinazolin-12-one;6,7,8,9,10,12-Hexahydroazepino[2,1-b]quinazoline-12-one;Azepino[2,1-b]quinazolin-12(6H)-one, 7,8,9,10-tetrahydro-
CBNumber: CB31339212
Molecular Formula: C13H14N2O
Formula Weight: 214.26
MOL File: 4425-23-4.mol

More

Less

Safety

HS Code: 2933998090
Toxicity: LD50 oral in mouse: 1250mg/kg

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation

Product number: CHM0156136
Product name: 7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE
Purity: 95.00%
Packaging: 1MG
Price: $597.89
Updated: 2021/12/16

American Custom Chemicals Corporation

Product number: CHM0156136
Product name: 7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE
Purity: 95.00%
Packaging: 10MG
Price: $631.85
Updated: 2021/12/16

American Custom Chemicals Corporation

Product number: CHM0156136
Product name: 7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE
Purity: 95.00%
Packaging: 5MG
Price: $633.99
Updated: 2021/12/16

AccelPharmtech

Product number: M1607
Product name: 7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one
Purity: 97.00%
Packaging: 1G
Price: $1950
Updated: 2021/12/16

AccelPharmtech

Product number: M1607
Product name: 7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one
Purity: 97.00%
Packaging: 5G
Price: $3300
Updated: 2021/12/16

More

Less

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Chemical Properties,Usage,Production

Uses

RLX (PD 139530) is a PI3K/Akt/FoxO3a signaling inhibitor, possessing significant therapeutic potential in experimental colon cancer. RLX can effectively modulate the tumor microenvironment, enhancing the efficacy of cancer immunotherapy. RLX demonstrates the ability to improve the retention time of therapeutic agents within the tumor microenvironment by utilizing advanced nanoparticle delivery systems. RLX can be integrated with various treatment modalities, such as chemotherapy and radiotherapy, to enhance overall tumor therapy effectiveness. RLX highlights the necessity for further research into the tumor microenvironment’s dynamics to develop more tailored treatment approaches for diverse tumor types.

References

[1] The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Suppliers

China 2 Finland 1 Ukraine 1 United States 3 Global 7

TargetMol Chemicals Inc.

Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 32435
Advantage: 58

TargetMol Chemicals Inc.

Tel: 15002134094
Email: marketing@targetmol.cn
Country: China
ProdList: 29357
Advantage: 58

Biosynth Biological Technology (Suzhou) Co Ltd

Tel: 51288865780
Email: sales@biosynth.com
Country: China
ProdList: 6051
Advantage: 58

TargetMol Chemicals Inc.

Tel: +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 19961
Advantage: 58

4425-23-4, 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-oneRelated Search:

2,3-Pentanoquinazoline-4(3H)-one

6,7,8,9,10,12-Hexahydroazepino[2,1-b]quinazoline-12-one

PD-139530

RLX

VASICINONE HCl (Deoxydihomo-'c'-)

7,8,9,10-Tetrahydro-6H-azepino[2,1-b]quinazolin-12-one

Azepino[2,1-b]quinazolin-12(6H)-one, 7,8,9,10-tetrahydro-

4425-23-4